Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Time to be "Overweight" Viking Therapeutics
04:00pm, Tuesday, 19'th Mar 2024
A rising obesity rate and the desire for a quick fix are driving the burgeoning weight loss industry. Stock Strategist Andrew Rocco explains why VKTX stands to benefit the most.
Warning: This Skyrocketing Stock Has a Hidden Risk
09:45am, Tuesday, 19'th Mar 2024
Viking Therapeutics is going to market with its first medicine for obesity. If that drug and its peers are widely adopted, many things may change.
Where Will Viking Therapeutics Be in 5 Years?
09:15am, Sunday, 17'th Mar 2024
Viking Therapeutics has a few promising metabolic disease programs. Its candidates for treating obesity are particularly lucrative.
Will Viking Therapeutics Get Acquired?
08:17am, Saturday, 16'th Mar 2024
Viking Therapeutics has a GLP-1 drug that could be a big player in the anti-obesity market. For big pharma, the stock could make for an attractive acquisition target.
2 Stocks That Have More Than Tripled This Year: Are They Buys?
09:45am, Friday, 15'th Mar 2024
Viking Therapeutics and Janux Therapeutics are flying high on the back of positive data readouts. However, there is a long road ahead and plenty of potential risks for both of these mid-cap biotechs.
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
05:50am, Friday, 15'th Mar 2024
Pfizer's pipeline already includes two obesity drugs. However, doubts about Pfizer's lead obesity program could make buying Viking a smart move.
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
02:25pm, Wednesday, 13'th Mar 2024
While the technology sector has been enjoying ridiculous returns, it's inevitable that a slowdown (or even a correction) may materialize, which brings to the table biotech stocks. This is just as inno
Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March
07:35am, Wednesday, 13'th Mar 2024
With the stock market trading around record highs, we have compiled three top stocks for long-term investors. Despite concerns regarding potential macroeconomic headwinds and global geopolitical insta
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
05:03am, Wednesday, 13'th Mar 2024
Viking is working on a weight-loss drug candidate that works in the same way as Eli Lilly's top-selling drug. The company released positive data recently, and the shares soared in the triple digits.
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
04:47pm, Saturday, 09'th Mar 2024
Viking Therapeutics recently unveiled positive clinical trial results for its anti-obesity medication. The treatment is in phase 2 trials, but its results suggest it could rival other weight loss drug
Wegovy and Zepbound Are King. Who's Coming for Their Crowns.
02:30am, Saturday, 09'th Mar 2024
Contenders are beginning to emerge from the lab, some with the potential to unseat Lilly's Zepbound and Novo's Wegovy.
3 Stock Winners That Are Up 1,000% or More in 2024
01:03pm, Friday, 08'th Mar 2024
Dig deep enough and find a story hot enough, and you can uncover potential stock winners up 1,000%. Look at Advanced Micro Devices (NASDAQ: AMD ), for example.
Viking (VKTX) Stock Down on Novo Nordisk's Obesity Pill Data
07:51am, Friday, 08'th Mar 2024
Viking Therapeutics (VKTX) falls as VK2735's placebo-adjusted mean weight loss after 13 weeks of treatment in a phase II study appears similar to Novo Nordisk's amycretin in a phase I study.
Why Viking Therapeutics Stock Is Plunging Today
12:05pm, Thursday, 07'th Mar 2024
Viking Therapeutics stock fell after Novo Nordisk reported positive phase 1 results for experimental obesity drug amycretin. Amycretin achieved similar weight loss as Viking's VK2735 did in a phase 2
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
05:50am, Wednesday, 06'th Mar 2024
Investors are excited about the opportunity for Viking's experimental weight-loss drug VK2735. Viking doesn't compare favorably against Lilly and Novo Nordisk in most categories.
